Articles

Singapore Not Likely To See Another Bumper Year For FDI

Country Risk / Singapore / Thu 18 Jan, 2024

Key View

  • We expect inward FDI to fall below 30% of GDP in 2023 and 2024.
  • A jump in retained earnings were behind the FDI increase in 2021 and 2022, and they notably did little to boost economic growth in Singapore.
  • The expected reduction in inward FDI will not pose risks to Singapore’s external balance, given ample foreign reserves and
Read More

Quick View: Lupin Achieves Three New Generic Approvals In The US Highlighting Continued Interest In Expanding Generics Portfolio

Pharmaceuticals / United States / Thu 18 Jan, 2024

The Latest: On January 14 2024, Lupin announced that it had received US FDA approval to market a generic version of propranolol hydrochloride extended-release capsules, used in the treatment of migraine and hypertension. The approval is significant as Lupin can offer a more affordable alternative to ANI Pharmaceuticals' Inderal LA extended

Read More

Sri Lanka’s Recovery Will Gain Pace In 2024

Country Risk / Sri Lanka / Tue 16 Jan, 2024

Key View

  • Sri Lanka’s economy returned to growth in Q323, and we think that output will rise by 3.5% in real terms in 2024.
  • The recovery will be driven by rising household spending, a recovering tourism sector, and increasing investment spending.
  • While we think that growth will accelerate in 2024 and 2025, output per person will not recover
Read More
Download Indicator Summary
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Clearbit Form
 

Thank you. Your download link will be emailed to you shortly.